SCHEMBL1907360

SCHEMBL1907360

Cc1ccn(-c2ccccn2)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
RAB9A P51151 2/20 0.63
NPC1 O15118 1/20 0.63
ATM Q13315 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
MTOR P42345 2/20 0.46
GRM5 P41594 1/20 0.46
GRIA1 P42261 4/20 0.44
CYP1A2 P05177 3/20 0.44
RPTOR Q8N122 1/20 0.44
MLST8 Q9BVC4 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
PDE10A Q9Y233 1/20 0.40
PDCD1 Q15116 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
MAPK10 P53779 1/20 0.39
ALKBH2 Q6NS38 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38651177 1.00 MAPT (0.63) MAPTSMN1; SMN2RAB9ANPC1ATM
SCHEMBL13514001 0.78 RAB9A (0.53) MAPTSMN1; SMN2RAB9ANPC1ATM
SCHEMBL197523 0.78 MAPT (1.00) MAPTSMN1; SMN2RAB9ANPC1ATM
SCHEMBL19119928 0.77 GRM5 (0.46) MAPTSMN1; SMN2RAB9ANPC1ATM
SCHEMBL2643353 0.77 GRM5 (0.46) MAPTSMN1; SMN2RAB9ANPC1ATM
SCHEMBL2160327 0.77 MPO (0.46) MAPTSMN1; SMN2MTORGRM5GRIA1
SCHEMBL28076029 0.77 GRM5 (0.46) MAPTSMN1; SMN2RAB9ANPC1ATM
SCHEMBL29563483 0.77 MPO (0.46) MAPTSMN1; SMN2MTORGRM5GRIA1
SCHEMBL3156955 0.77 GRM5 (0.46) MAPTSMN1; SMN2RAB9ANPC1ATM
SCHEMBL8086526 0.77 GRM5 (0.46) SMN1; SMN2RAB9AMTORGRM5GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0389189-B1 Diazepine antiallergy agents PFIZER LTD (GB) 1994-05-18 EP claimed
US-5008263-A Platelet activating factor antagonists; antiallergens; antiinflammatory agents PFIZER INC. (US) 1991-04-16 US claimed
EP-0389189-A2 Diazepine antiallergy agents Pfizer Limited (GB) 1990-09-26 EP claimed
EP-3400220-B1 PYRAZOLE DERIVATIVES HUA MEDICINE SHANGHAI LTD (CN) 2021-03-24 EP disclosed
EP-2678346-B9 METAL COMPLEXES FOR USE AS DOPANTS AND OTHER USES ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) 2018-08-08 EP disclosed
US-10038150-B2 Metal complexes for use as dopants and other uses ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2018-07-31 US disclosed
EP-2678346-B1 METAL COMPLEXES FOR USE AS DOPANTS AND OTHER USES ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) 2018-04-04 EP disclosed
US-9779879-B2 Redox couple for electrochemical and optoelectronic devices ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2017-10-03 US disclosed
WO-2017117708-A1 PYRAZOLE DERIVATIVES HUA MEDICINE (SHANGHAI) LTD. (CN) 2017-07-13 WO disclosed
US-9559321-B2 Metal complexes for use as dopants and other uses ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2017-01-31 US disclosed
US-20160233439-A1 METAL COMPLEXES FOR USE AS DOPANTS AND OTHER USES ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) EPFL-TTO (CH) 2016-08-11 US disclosed
EP-2233493-A1 Macrolides Pfizer Products Inc. (US) 2010-09-29 EP disclosed
EP-1836211-B1 MACROLIDES PFIZER PROD INC (US) 2010-03-03 EP disclosed
WO-2010017047-A1 THERAPEUTIC COMPOUNDS MERCK & CO., INC. (US) 2010-02-11 WO disclosed
CN-1322254-A Small volume in vitro analytical sensor containing diffusible or non-leachable redox mediator THERASENSE INC (US) 2001-11-14 CN disclosed
EP-0389189-B1 Diazepine antiallergy agents PFIZER LTD (GB) 1994-05-18 EP disclosed
US-5008263-A Platelet activating factor antagonists; antiallergens; antiinflammatory agents PFIZER INC. (US) 1991-04-16 US disclosed
EP-0389189-A2 Diazepine antiallergy agents Pfizer Limited (GB) 1990-09-26 EP disclosed
US-4881965-A CONTROLLING WILD OATS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1989-11-21 US disclosed
EP-0318602-A1 Pyrazolesulfonamide derivative, process for its production and herbicide containing it NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1989-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038150-B2 Metal complexes for use as dopants and other uses SOD1, DDT, SOD3 MAPT 3516/4885SMN1; SMN2 2031/4885RAB9A 1331/4885
US-20160233439-A1 METAL COMPLEXES FOR USE AS DOPANTS AND OTHER USES SOD1, DDT, SOD3 MAPT 3516/4885SMN1; SMN2 2031/4885RAB9A 1331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.